Skip to content

effect of orabase containing portulaca extract in recurrent minor aphthea treatment

Evaluation of effect of orabase containing portulaca extract in recurrent aphthous stomatitis treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191012045067N4
Enrollment
30
Registered
2021-12-02
Start date
2021-10-23
Completion date
Unknown
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recurrent aphthous stomatitis. Recurrent oral aphthae

Interventions

Intervention 1: Intervention group: People with recurrent aphthous ulcer useorabase containing portulaca extract 4 times a day for 5 days (The patient asked to use the orabase containing portulaca ext

Sponsors

Vice Chancellor for Research, Zahedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The existence of 1-5 wounds less than 24h its size of less than 10mm (if there is more than one wound, the average diameter of all wounds will prevail) the pain existence in the affected area the age above 18 years lack of history of drug hypersensitivity non pregnant and no lactation Lack of history of systemic disease Lack of non-steroid anti-inflammatory medication or oral antihistamines use one month before the study entrance lack of treatment with systemic or immunosuppressive medications a month before the study entrance treatment of wounds with each drug before study entrance lack of treatment with systemic antibiotics 2weeks before the study entrance the absence of aphthea ulcer adjacent trauma ulcers caused by sharp tooth edges, broken restorative , orthodontic appliance or partial denture prosthesis

Exclusion criteria

Exclusion criteria: No attend of person with recurrent aphthous stomatitis in fallow up period non-controlled diabetes non-controlled hypertension pregnancy or lactation active or known infection severe mental disorder require of treatment with antibiotics during the desired treatment

Design outcomes

Primary

MeasureTime frame
Recurrent aphthous stomatitis. Timepoint: Day Zero, second, seventh after the start of treatment. Method of measurement: Visual Analogue Scale,Periodontal probe.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoomeh Shirzaiy

Zahedan University of Medical Sciences

shirzaiy@gmail.com+98 54 3344 1824

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026